Zealand Pharma A/S ZLDPF Stock
Zealand Pharma A/S Price Chart
Zealand Pharma A/S ZLDPF Financial and Trading Overview
| Zealand Pharma A/S stock price | 50 USD |
| Previous Close | 50 USD |
| Open | 50 USD |
| Bid | 47.43 USD x 30000 |
| Ask | 49.02 USD x 10000 |
| Day's Range | 50 - 50 USD |
| 52 Week Range | 35.93 - 83.12 USD |
| Volume | 330 USD |
| Avg. Volume | 781 USD |
| Market Cap | 3.44B USD |
| Beta (5Y Monthly) | 0.597 |
| PE Ratio (TTM) | 8.266775 |
| EPS (TTM) | 6.41 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
ZLDPF Valuation Measures
| Enterprise Value | -10701023232 USD |
| Trailing P/E | 8.266775 |
| Forward P/E | -43.543102 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.7408565 |
| Price/Book (mrq) | 1.2453952 |
| Enterprise Value/Revenue | -2.304 |
| Enterprise Value/EBITDA | -4.604 |
Trading Information
Zealand Pharma A/S Stock Price History
| Beta (5Y Monthly) | 0.597 |
| 52-Week Change | -23.46% |
| S&P500 52-Week Change | 18.35% |
| 52 Week High | 83.12 USD |
| 52 Week Low | 35.93 USD |
| 50-Day Moving Average | 46.39 USD |
| 200-Day Moving Average | 55.69 USD |
ZLDPF Share Statistics
| Avg. Volume (3 month) | 781 USD |
| Avg. Daily Volume (10-Days) | 669 USD |
| Shares Outstanding | 68.11M |
| Float | 55.43M |
| Short Ratio | N/A |
| % Held by Insiders | 0.53% |
| % Held by Institutions | 42.71% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | June 30, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 59.02% |
| Operating Margin (ttm) | 85.92% |
| Gross Margin | 100.00% |
| EBITDA Margin | 50.04% |
Management Effectiveness
| Return on Assets (ttm) | 7.80% |
| Return on Equity (ttm) | 16.31% |
Income Statement
| Revenue (ttm) | 4.64B USD |
| Revenue Per Share (ttm) | 65.97 USD |
| Quarterly Revenue Growth (yoy) | -50.60% |
| Gross Profit (ttm) | 4.64B USD |
| EBITDA | 2.32B USD |
| Net Income Avi to Common (ttm) | 2.74B USD |
| Diluted EPS (ttm) | 6.11 |
| Quarterly Earnings Growth (yoy) | -48.29% |
Balance Sheet
| Total Cash (mrq) | 14.46B USD |
| Total Cash Per Share (mrq) | 208.49 USD |
| Total Debt (mrq) | 411M USD |
| Total Debt/Equity (mrq) | 2.28 USD |
| Current Ratio (mrq) | 13.979 |
| Book Value Per Share (mrq) | 40.557407 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -1753067008 USD |
| Levered Free Cash Flow (ttm) | -2063679360 USD |
Profile of Zealand Pharma A/S
| Country | United States |
| State | N/A |
| City | Søborg |
| Address | Sydmarken 11 |
| ZIP | 2860 |
| Phone | 45 88 77 36 00 |
| Website | https://www.zealandpharma.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 578 |
Zealand Pharma A/S, a biotechnology company, engages in the discovery, development, and commercialization of peptide-based medicines in Denmark and the United States. The company has a portfolio of medicines focusing on gastrointestinal and metabolic diseases, and other specialty disease areas with unmet medical needs. It also provides Zegalogue, a single use syringe or autoinjector for the treatment of severe hypoglycemia; and Dasiglucagon bi-hormone artificial pancreas systems containing insulin and dasiglucagon. Its pipeline includes Dasiglucagon for treating congenital hyperinsulinism. In addition, the company developing glepaglutide, a long acting GLP-2 analog, which is in Phase III clinical trials for the treatment of short bowel syndrome. The company was incorporated in 1997 and is based in Søborg, Denmark.
Q&A For Zealand Pharma A/S Stock
What is a current ZLDPF stock price?
Zealand Pharma A/S ZLDPF stock price today per share is 50 USD.
How to purchase Zealand Pharma A/S stock?
You can buy ZLDPF shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Zealand Pharma A/S?
The stock symbol or ticker of Zealand Pharma A/S is ZLDPF.
Which industry does the Zealand Pharma A/S company belong to?
The Zealand Pharma A/S industry is Biotechnology.
How many shares does Zealand Pharma A/S have in circulation?
The max supply of Zealand Pharma A/S shares is 67.98M.
What is Zealand Pharma A/S Price to Earnings Ratio (PE Ratio)?
Zealand Pharma A/S PE Ratio is 7.80031200 now.
What was Zealand Pharma A/S earnings per share over the trailing 12 months (TTM)?
Zealand Pharma A/S EPS is 6.41 USD over the trailing 12 months.
Which sector does the Zealand Pharma A/S company belong to?
The Zealand Pharma A/S sector is Healthcare.
